AFP and hepatocellular carcinoma: Concerning sirolimus, the prolonged use of this medication for a period exceeding three months significantly improves the outcomes of individuals undergoing liver transplantation for HCC, notably among those exhibiting greater tumor activity as evidenced by elevated alpha-fetoprotein (AFP) levels (NCT00355862) [336].